Related Experiment Videos
Glycosphingolipid changes induced by advanced glycation end-products
A Natalizio1, D Ruggiero, M Lecomte
1Diabetic Microangiopathy Unit, LIPHA-INSERM U352, INSA-Lyon, Villeurbanne, France.
Biochemical and Biophysical Research Communications
|February 17, 2001
Summary
Advanced glycation end-products (AGEs) alter retinal microvascular cell glycosphingolipids, a key factor in diabetic retinopathy. AGEs increase most glycosphingolipids but decrease GD3 in pericytes, revealing a novel metabolic pathway.
Area of Science:
- Ophthalmology
- Metabolic Research
- Cell Biology
Background:
- Diabetic retinopathy is a leading cause of vision loss.
- Advanced glycation end-products (AGEs) are implicated in diabetic complications.
- The role of AGEs in retinal microvascular changes requires further elucidation.
Purpose of the Study:
- To investigate the impact of AGEs on glycosphingolipids in retinal microvascular cells.
- To explore a potential pathogenic mechanism in diabetic retinopathy.
Main Methods:
- Incubation of retinal endothelial cells and pericytes with AGEs.
- Quantitative analysis of glycosphingolipid levels.
- Analysis of glycosphingolipid profiles and GM3 fatty acids.
Main Results:
- AGEs significantly increased most glycosphingolipids (25-115%) in retinal endothelial cells and pericytes.
- A specific ganglioside, GD3, decreased by 35% in pericytes.
- No qualitative changes in glycosphingolipid profiles or GM3 fatty acids were observed.
Conclusions:
- AGEs induce quantitative alterations in retinal microvascular cell glycosphingolipids.
- These metabolic changes represent a novel effect of AGEs.
- This finding may contribute to understanding microvascular damage in diabetic retinopathy.